These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 12784269

  • 21. Sleep attacks in Parkinson's disease: a clinical and polysomnographic study.
    Pacchetti C, Martignoni E, Terzaghi M, Zangaglia R, Mancini F, Nappi G, Manni R.
    Neurol Sci; 2003 Oct; 24(3):195-6. PubMed ID: 14598084
    [Abstract] [Full Text] [Related]

  • 22. [Sleep attacks and pergolide mesylate].
    García Ruiz PJ, Hernández J, Cantarero S, Fanjul S.
    Neurologia; 2001 Feb; 16(2):92. PubMed ID: 11257938
    [No Abstract] [Full Text] [Related]

  • 23. Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers.
    Ferreira JJ, Desboeuf K, Galitzky M, Thalamas C, Brefel-Courbon C, Fabre N, Senard JM, Montastruc JL, Sampaio C, Rascol O.
    Eur J Neurol; 2006 Mar; 13(3):209-14. PubMed ID: 16618334
    [Abstract] [Full Text] [Related]

  • 24. Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease.
    Nissen T, Newman EJ, Grosset KA, Daghem M, Pal G, Stewart M, Odin P, Macphee GJ, Grosset DG.
    Scott Med J; 2012 Nov; 57(4):217-20. PubMed ID: 23002158
    [Abstract] [Full Text] [Related]

  • 25. Role of dopamine receptor agonists in the treatment of early Parkinson's disease.
    Bonuccelli U, Del Dotto P, Rascol O.
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S44-53. PubMed ID: 20123557
    [Abstract] [Full Text] [Related]

  • 26. Ropinirole in the symptomatic treatment of Parkinson's disease.
    Brooks DJ, Torjanski N, Burn DJ.
    J Neural Transm Suppl; 1995 Dec; 45():231-8. PubMed ID: 8748630
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants.
    Poryazova R, Benninger D, Waldvogel D, Bassetti CL.
    Eur Neurol; 2010 Dec; 63(3):129-35. PubMed ID: 20090346
    [Abstract] [Full Text] [Related]

  • 31. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.
    Linazasoro G, Spanish Dopamine Agonists Study Group.
    J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Nighttime sleep problems and daytime sleepiness in Parkinson's disease.
    Verbaan D, van Rooden SM, Visser M, Marinus J, van Hilten JJ.
    Mov Disord; 2008 Jan; 23(1):35-41. PubMed ID: 17960797
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease.
    Gómez-Esteban JC, Zarranz JJ, Lezcano E, Velasco F, Ciordia R, Rouco I, Losada J, Bilbao I.
    Mov Disord; 2006 Jul; 21(7):983-8. PubMed ID: 16602112
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.